Drugs / Starch
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00318942 | Feb 2003 → Aug 2012 | — | University of Versailles | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Starch | “Gelatines, Albumine, Starch, or any other colloids, at the necessary dose to restore hemodynamic (starch cumulative daily dose should not exceed 35/40 ml/kg), for all ICU stay” NCT00318942 ↗ |
| Known as | Bio-sorb | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108866 ↗ |
| Route | Intravenous | “Evidence supporting the choice of intravenous colloid vs crystalloid solutions for management of hypovolemic shock remains unclear.” PMID 24108515 ↗ Nov 2013 |